Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Unicycive Therapeutics Inc
UNCYCurrent price
0.48 USD
-0.031 USD (-6.07%)
Last closed
0.48 USD
Company
www.unicycive.com
ISIN
US90466Y1038
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
55 670 156 USD
Yield for 12 month
-7.97 %
1Y
3Y
5Y
10Y
15Y
UNCY
Unicycive Therapeutics, Inc., a biotechnology company, develops treatments for various medical conditions in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb (Oxylanthanum Carbonate), which is being developed for the treatment of hyperphosphatemia in patients with chronic kidney disease. Unicycive Therapeutics, Inc. has license agreements with Shilpa Medicare Ltd; Sphaera Pharma Pte. Ltd.; Syneos Health LLC; Inotiv; Lee's Pharmaceutical (HK) Limited; Celerion; and Lotus International Pte Ltd. The company was incorporated in 2016 and is based in Los Altos, California. Address: 4300 El Camino Real, Los Altos, CA, United States, 94022
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5.25 USDP/E ratio
–Dividend Yield
–Current Year
+675 000 USD
Last Year
+951 000 USD
Current Quarter
–
Last Quarter
–
Current Year
+391 000 USD
Last Year
+951 000 USD
Current Quarter
–
Last Quarter
-284 000 USD
Key Figures UNCY
1 year
3 years
5 years
10 years
EBITDA
-28 842 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-53.37 %
PEG Ratio
–
Return On Equity TTM
-121.76 %
Wall Street Target Price
5.25 USD
Revenue TTM
–
Book Value
-0.34 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.36 USD
Diluted Eps TTM
-0.36 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics UNCY
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History UNCY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation UNCY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
46.9999
Price Sales TTM
62.819
Enterprise Value EBITDA
-1.0306
Price Book MRQ
4.8926
Financials UNCY
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators UNCY
For 52 weeks
0.2 USD
1.82 USD
50 Day MA
0.42 USD
Shares Short Prior Month
993 824
200 Day MA
0.79 USD
Short Ratio
0.68
Shares Short
1 045 124
Short Percent
1.2 %
BeatStart